A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William T Smith, MD
Celgene Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- North American Research Institute
Azusa, California, United States
- West Glendale Dialysis
Glendale, California, United States
- California Institute of Renal Research
La Mesa, California, United States
- Academic Medical Center
Los Angeles, California, United States
- Academic Medical Research Institute
Los Angeles, California, United States
- Nephrology Specialist Medical Group
Orange, California, United States
- Pines Clinical Research Inc.
Pembroke Pines, Florida, United States
- University of Kentucky
Lexington, Kentucky, United States
- Fresenius Medical Care North America Mi
Kalamazoo, Michigan, United States
- Davita Clinical Research
Minneapolis, Minnesota, United States
- Nephrology and Hypertension Associates, Ltd
Tupelo, Mississippi, United States
- St. Louis University Medical Center
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Kidney Specialists of Southen Nevada
Las Vegas, Nevada, United States
- Brookview Hill Research Associates, Llc
Winston-Salem, North Carolina, United States
- Metrohealth Medical Systems
Cleveland, Ohio, United States
- Northeast Clinical Research Center
Bethlehem, Pennsylvania, United States
- Nephrology Associates, Pc
Nashville, Tennessee, United States
- Beechnut Dialysis Center
Houston, Texas, United States
- Corva Kidney Center Webster
Houston, Texas, United States
- Gessner Dialysis Center
Houston, Texas, United States
- Miracle Medical Clinic
Houston, Texas, United States
- Tyler Nephrology Associates, Pc
Tyler, Texas, United States
- University of Virginia at University Ave.
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2010
- Primary completion
- 7 Mar 2016
- Completion
- 7 Mar 2016
- Last update posted
- 1 Mar 2024
- Registered enrollment
- 50
- Registry id
- NCT01146574
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.